...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Veterinary Applications?

imtesty - As Bear mentioned in his post I also remember hearing that there was a possibility of early revenue from the animal treatment path from past AGM's and other presentations. I would suggest you get hold of Clayton or Sarah and enquiring about this. Please let us know what they tell you.

tada

Share
New Message
Please login to post a reply